What's behind Core Scientific's latest stock surge?

Traders Union
All News
Stocks
Core Scientific rises 4.58% today

Highlights

Shares of Core Scientific rose 4.58% to $18.17, trading near the session high after opening with an upside gap.
The stock trades above short-term support but remains below key medium- and long-term moving averages, with consolidation expected around current levels.
Technical indicators show prevailing negative momentum and a very high probability of a downward price move toward $17.25 over the next five trading days.

Anton Kharitonov, expert at Traders Union, sees the recent 4.58% advance in Core Scientific as a short-lived technical bounce. He notes the stock only sits above its 20-day average, while weakness persists over the 50- and 200-day timeframes. Most momentum signals flash sell or neutral, and institutional or fundamental news is notably absent, offering no support to reverse the current downtrend. Kharitonov highlights the negative divergence between daily gains and poor underlying structure. "Sustained downside pressure is the primary risk for traders until clear long-term reversal cues emerge," he says.

Viktoras Karapetjanc, expert at Traders Union, acknowledges Core Scientific's positive close above the 20-day average with strong intraday action. He finds opportunity in the bullish 50-day versus 200-day relationship, suggesting structural potential for buyers. Karapetjanc notes that, despite the lack of news catalysts, price resilience and improving short-term technicals could tempt forward-looking investors. With volatility elevated, long setups may arise on further strength. "I see the market offering an early-stage entry for those seeking high-conviction upside — the bullish structure remains promising," he states.

Parshwa Turakhiya, analyst, observes that Core Scientific is riding oversold momentum but faces stiff selling pressure overall. He stresses that the bounce to $18.17 is near session highs, yet most momentum and oscillator signals suggest caution. The analyst points to a likely sideways or pullback phase given the dominance of sell signals and lack of supporting news. Short-term traders might watch the $18.38 breakout or $17.99 breakdown for action. "For now, I’d play it scenario by scenario — action is brewing, but discipline is key in these conditions," he advises.

Short-term support contrasts with dominant negative momentum signals

Core Scientific trades above its 20-day moving average at $17.99 but remains below the 50-day at $20.36 and 200-day at $19.73, suggesting tentative short-term support with ongoing medium- and long-term selling pressure. The nearest ceiling is the session high at $18.38, while support aligns with the 20-day average at $17.99; a bullish longer-term setup is indicated by the positive 50-day versus 200-day relationship. The MACD currently registers a Strong Sell and the Average Directional Index (ADX) produces a Sell signal, highlighting negative momentum. The Relative Strength Index (RSI) stands at 42.48 with a Sell indication, while the Stochastic RSI at 59.83 and Commodity Channel Index (CCI) at -33.31 both show neutral bias. Bull/Bear Power (BBP) is positive at 0.29, indicating buyers dominate intraday momentum, with an Oversold forecast. The stock is trading at $18.17, up $0.80 or 4.58% on the day, after opening with an upside gap of approximately $0.20 or 1.15%. Price now sits near the session high, and intraday volatility stands at 4.79%. Momentum signals are mostly negative despite today’s strength and buying bias, highlighting a divergence between the daily gain and underlying momentum.

Previously it was reported that Core Scientific was facing mixed momentum signals and pivotal resistance, reflecting uncertainty in its near-term price direction. The current technical outlook reinforces bearish pressure despite today's gains, with traders advised to monitor the $18.38 level as a potential pivot point for any shift in momentum.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.